as he stated. Furthermore, in early August 2021, Dr. Boon still confirmed that the vaccines would be import within August 2021 but later he admitted that such vaccines could not be imported as he
price for the Company reduced by 10% compared to Q2 2019 (from 19891 THB/Ton in Q2 2019 to 17915 THB/ton in Q3 2019). The sharp decline in the Finished Goods has also led to a decline in Raw material
sales volumes. The sharp decline in the Finished Goods prices has also led to a decline in Raw material prices and the Company suffered devaluation loss on Finished Goods stock, Raw Material in stock and
continuous decline in global HRC prices and concerns about the growing spread of global epidemic of COVID 2019 towards the end of 1st quarter of 2020. This also resulted resulting in slowing orders from
ended 31 July 2017, INGRS had sales revenue of THB 1,336.05 million, a decline by 6.13% from the 6-months period ended 31 July 2016 of THB 1,423.28 million. Such sales revenue decline was contributed
amounting of 3,029.84 Million Baht or 388.85 Million Baht increased when compared to December 31, 2017 of 2,640.99 Million Baht as cash and cash equivalents decline of 44.33 Million Baht, more temporary
Professor Dr. Thanes Weerasiri confirmed that post-earthquake inspections of buildings that requested assessment reveal no significant damage to their infrastructure, with the majority receiving green level
236.62 Million Baht decreased or 13.82 percent when compared to same period of previous year of 1,688.47 Million Baht thus subsidiaries has revenue from selling wire and decline in services somehow
236.62 Million Baht decreased or 13.82 percent when compared to same period of previous year of 1,688.47 Million Baht thus subsidiaries has revenue from selling wire and decline in services somehow
subsidiaries has total revenue of 493.86 Million Baht or decline of 46.10 percent when compared to the same period of previous year had 916.32 Million Baht in revenue the details as follow: Revenue from sales